GENinCode
Pre-clinicalGENinCode develops genetic testing and risk assessment tools for cardiovascular and metabolic diseases.
Founded
2014
Focus
Diagnostics
About
GENinCode develops genetic testing and risk assessment tools for cardiovascular and metabolic diseases.
Funding History
2Total raised: $12.5M
Series A$10MParkwalk AdvisorsSep 15, 2021
Seed$2.5MUndisclosedJun 15, 2020
Company Info
TypePrivate
Founded2014
LocationOxford, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile